136 related articles for article (PubMed ID: 35559890)
1. PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study.
Alavi SE; Koohi Moftakhari Esfahani M; Raza A; Adelnia H; Ebrahimi Shahmabadi H
NanoImpact; 2022 Jan; 25():100384. PubMed ID: 35559890
[TBL] [Abstract][Full Text] [Related]
2. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into
Ferreira M; Pinto SN; Aires-da-Silva F; Bettencourt A; Aguiar SI; Gaspar MM
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801281
[No Abstract] [Full Text] [Related]
3. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
Oh DH; Kim JJ; Kim J; Seong H; Lee SJ; Kim YC; Kim EJ; Jung IY; Jeong WY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
BMC Infect Dis; 2018 Jan; 18(1):60. PubMed ID: 29378565
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
[TBL] [Abstract][Full Text] [Related]
5. Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Leonard SN
PLoS One; 2012; 7(7):e42103. PubMed ID: 22848719
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
[TBL] [Abstract][Full Text] [Related]
7. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Twilla JD; Algrim A; Adams EH; Samarin M; Cummings C; Finch CK
Am J Med Sci; 2020 Jul; 360(1):35-41. PubMed ID: 32376001
[TBL] [Abstract][Full Text] [Related]
9. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms.
Garcia MAR; Theodoro RS; Sardi JCO; Santos MB; Ayusso GM; Pavan FR; Costa AR; Santa Cruz LM; Rosalen PL; Regasini LO
Bioorg Chem; 2021 Nov; 116():105279. PubMed ID: 34509799
[TBL] [Abstract][Full Text] [Related]
11. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
Lee S; Choe PG; Song KH; Park SW; Kim HB; Kim NJ; Kim EC; Park WB; Oh MD
Antimicrob Agents Chemother; 2011 Nov; 55(11):5122-6. PubMed ID: 21825299
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections.
Rukavina Z; Šegvić Klarić M; Filipović-Grčić J; Lovrić J; Vanić Ž
Int J Pharm; 2018 Dec; 553(1-2):109-119. PubMed ID: 30312749
[TBL] [Abstract][Full Text] [Related]
15. Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
Leonard SN; Supple ME; Gandhi RG; Patel MD
Antimicrob Agents Chemother; 2013 Jun; 57(6):2678-83. PubMed ID: 23545527
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models.
Liu Y; Ren Y; Li Y; Su L; Zhang Y; Huang F; Liu J; Liu J; van Kooten TG; An Y; Shi L; van der Mei HC; Busscher HJ
Acta Biomater; 2018 Oct; 79():331-343. PubMed ID: 30172935
[TBL] [Abstract][Full Text] [Related]
18. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.
Bauer J; Siala W; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2013 Jun; 57(6):2726-37. PubMed ID: 23571532
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Biofilm Formation and Antibiotic Resistance in MRSA and MSSA Isolated from Clinical Samples in Iran: A Systematic Review and Meta-Analysis.
Hosseini M; Shapouri Moghaddam A; Derakhshan S; Hashemipour SMA; Hadadi-Fishani M; Pirouzi A; Khaledi A
Microb Drug Resist; 2020 Sep; 26(9):1071-1080. PubMed ID: 32159447
[No Abstract] [Full Text] [Related]
20. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Sakoulas G; Olson J; Yim J; Singh NB; Kumaraswamy M; Quach DT; Rybak MJ; Pogliano J; Nizet V
Antimicrob Agents Chemother; 2016 Nov; 60(11):6609-6618. PubMed ID: 27572414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
